Abbott Fights $3.5M Verdict In GSK Suit Over Norvir

Law360, New York (August 8, 2011, 10:11 PM EDT) -- Abbott Laboratories sought Friday to overturn a $3.5 million jury verdict in a dispute with GlaxoSmithKline PLC over a licensing deal for Norvir, having already fought off GSK's antitrust challenge over its decision to drastically raise prices for the HIV drug.

The drugmaker asked U.S. District Judge Claudia Wilken to set aside the verdict that Abbott broke an implied covenant of good faith and fair dealing when it raised the price for Norvir nearly four-fold a year after entering into a licensing agreement allowing GSK to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.